Literature DB >> 6995328

Modification of bacterial serum susceptibility by rifampin.

W J Alexander, C G Cobbs, R Curtiss.   

Abstract

A subinhibitory concentration of rifampin converted a strain of Escherichia coli from serum resistant to serum susceptible. When continually cultured in nutrient broth containing 1.5 microgram of rifampin per ml, this strain of E. coli became susceptible to killing by both normal human serum and normal rabbit serum. Copared to the original strain, the rifampin-treated E. coli displayed no detectable change in adherence capability, but appeared less virulent in the rabbit model of endocarditis. A rifampin-resistant mutant of the E. coli strain was not found to undergo conversion to serum susceptibility upon culture in rifampin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995328      PMCID: PMC551039          DOI: 10.1128/iai.28.3.923-926.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Lysis of gram-negative bacteria by serum.

Authors:  D ROWLEY; A C WARDLAW
Journal:  J Gen Microbiol       Date:  1958-04

2.  Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding.

Authors:  A B Nesburn; M T Green; M Radnoti; B Walker
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum.

Authors:  A Fietta; E Romero; A G Siccardi
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Observations concerning the pathogenesis of E. coli infections in mice.

Authors:  D N Medearis; J F Kenny
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

5.  The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.

Authors:  C J Howard; A A Glynn
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

6.  Protective role of complement in experimental Escherichia coli endocarditis.

Authors:  D T Durack; P B Beeson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

7.  Adherence of bacteria to heart valves in vitro.

Authors:  K Gould; C H Ramirez-Ronda; R K Holmes; J P Sanford
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

8.  Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.

Authors:  W R McCabe; B Kaijser; S Olling; M Uwaydah; L A Hanson
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

9.  Effects of antibiotic resistance plasmids on the bactericidal activity of normal rabbit serum.

Authors:  A M Reynard; M E Beck; R K Cunningham
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Plasmid carriage and the serum sensitivity of enterobacteria.

Authors:  P W Taylor; C Hughes
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

View more
  4 in total

1.  How antibiotics augment host defenses.

Authors:  P K Peterson
Journal:  Eur J Clin Microbiol       Date:  1982-12       Impact factor: 3.267

2.  Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying poly-C9 deposition.

Authors:  J E Schweinle; M Nishiyasu
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

3.  Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection.

Authors:  J J Hoogeterp; H Mattie; A M Krul; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains.

Authors:  P W Taylor; H Gaunt; F M Unger
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.